Flot-2 Expression Correlates With EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0132190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

MUC1 (Episialin) Expression in Non-Small Cell Lung Cancer Is Independent of EGFR and C-erbB-2 Expression and Correlates With Poor Survival in Node Positive Patients

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1998English

Upregulated Expression of miR-421 Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer

Cancer Management and Research
Oncology
2018English

Flotillin2 Expression Correlates With HER2 Levels and Poor Prognosis in Gastric Cancer

PLoS ONE
Multidisciplinary
2013English

Nuclear EGFR Protein Expression Predicts Poor Survival in Early Stage Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2013English

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

PLoS ONE
Multidisciplinary
2014English

Platelet-Derived Endothelial Cell Growth Factor Expression Correlates With Tumour Angiogenesis and Prognosis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1997English

Protein Expression of Programmed Death 1 Ligand 1 and Ligand 2 Independently Predict Poor Prognosis in Surgically Resected Lung Adenocarcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Overexpression of lncRNA EGFR‑AS1 Is Associated With a Poor Prognosis and Promotes Chemotherapy Resistance in Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy